Beckman Aims Rejuvenated SNPstream At Underserved Mid-Market Facilities | GenomeWeb

Beckman Coulter will significantly improve on a recently acquired genotyping product in the hopes of dominating the middle-market research community, SNPtech Reporter has learned.

In two weeks, the genomics tool giant intends to roll out a smaller and more powerful version of the SNPstream genotyping platform it obtained from Orchid Biosciences late last year — but the trick will be not to make it too powerful.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.